Skip to main content

Einbindung neuer In-vitro-Diagnostika in die GKV (Teil 2)

Lösungsansätze aus vergleichender Perspektive

Medizinrecht volume 39, pages 964–970 (2021)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Author information

Authors and Affiliations

  1. Fakultät 11 – Fakultät für angewandte Sozialwissenschaften, Hochschule München, Am Stadtpark 20, 81243, München, Deutschland

    Simone von Hardenberg

  2. Max-Planck-Institut für Sozialrecht und Sozialpolitik, Amalienstraße 33, 80799, München, Deutschland

    Irene Domenici

  3. Fakultät Sozialwesen – Studienrichtung Sozialmanagement, Duale Hochschule Baden-Württemberg Heidenheim, Wilhelmstraße 10, 89518, Heidenheim a.d. Brenz, Deutschland

    Roman Grinblat LL.M.

Authors
  1. Simone von Hardenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irene Domenici
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roman Grinblat LL.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

von Hardenberg, S., Domenici, I. & Grinblat, R. Einbindung neuer In-vitro-Diagnostika in die GKV (Teil 2). MedR 39, 964–970 (2021). https://doi.org/10.1007/s00350-021-6004-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00350-021-6004-x